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Summary Radiotherapy after conservative surgery causes fat necrosis, fibrosis, skin thickening and other parenchymal distortion of the
breast. The interpretation of a mammogram of the irradiated breast may therefore be difficult. We studied the effect of radiotherapy on the
interpretation of the routine mammography used in the follow-up of breast cancer patients. A total of 144 low-risk breast cancer patients were
randomized to radiotherapy or to no further treatment after conservative surgery. The first routine follow-up mammography was performed
18 months after surgery and every 18 months after that. The number of mammography examinations was estimated per patient and per
follow-up year. The number of extra diagnostic tests and the occurrence of positive findings were assessed per mammography session and
per follow-up year. Further diagnostic tests prompted by difficulties in interpreting the mammogram were performed to an extent of 0.19 per
mammography examination in the radiotherapy group and of 0.15 in the non-radiotherapy group, i.e. 1.3 times more often. Findings that
turned out to be negative at confirmation were 2.0 times (P < 0.05) more common in the radiotherapy group. These false-positive findings
were more common in the radiotherapy group than in the surgery group and only shortly after treatment. Mammography is more difficult to
interpret after radiotherapy than after conservative surgery alone, especially shortly after treatment, and more often involves extra diagnostic
tests and findings that will be negative at confirmation.
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Because mammography has proved to be a valid test for screening it
is assumed also to be effective in the follow-up of breast cancer
patients. Operation and radiotherapy cause different changes in the
breast that may cause difficulties in interpretation ofmammography,
resulting in underdiagnosis of recurrence. On the other hand, over-
diagnosis in terms of a positive finding, which turns out to be nega-
tive at confirmation, causes unnecessary fear and uncertainty to the
patient. The aim of this study was to ascertain whether follow-up
mammography was more difficult to interpret after conservative
treatment ofbreast carcinoma ifradiotherapy was administered than
ifthe breast was treated with segmental resection alone.
PATIENTS AND METHODS
This prospective, randomized study was carried out in Tampere
University Hospital during the years 1990-95. All consecutive
low-risk breast cancer patients were randomized to have radio-
therapy after segmental resection or to have no further therapy.
Small invasive carcinomas <2 cm without evidence of an exten-
sive intraductal component (EIC), node negative, histological
grade I or II, c-erbB-negative, DNA-diploid with low S-phase
fraction (< 8%), free margins in operation . 1 cm and over 40-
year-old woman were the criteria for low risk. Patients who had
Received 13 October 97
Revised 5 February 98
Accepted 9 February 98
Correspondence to: K Holli
small tumour size (diameter < 5 mm) were also considered to have
low-risk breast cancer even if biological measurements were not
performed. Hormone receptors were measured in 81 % of cases
and all were progesterone receptor (PgR)-positive. Ploidy and
c-erbB were measured in 69% ofcases and all ofthese were DNA
diploid and c-erbB negative.
There were 144 patients included in the study during the 5-year
accrual period. All patients had segmental resection along the
fascia level with at least 1 cm free margins. The axilla was
dissected via a separate incision to levels I and II. Patients were
randomized after surgery to receive radiotherapy or not.
Radiotherapy was commenced within 8 weeks after surgery. The
whole breast and chest wall were included in the treated target
volume. The total radiation dose was 50 Gy. Radiotherapy was
given five times per week in 2 Gy per fraction. Radiotherapy was
performed using the two opposing tangential fields technique by
photons from a 2- to 6-MV linear accelerator. The isodose repre-
senting the minimum target-absorbed dose was defined as 95% of
the specification dose. No boost or bolus was used. None of the
patients received adjuvant hormone or chemotherapy.
The follow-up was organized in the oncological outpatient
department. Clinical examination was performed every third
month during the first year, every fourth month during the second
and every sixth month thereafter. Follow-up mammography of
both breasts was carried out routinely every 18 months and more
frequently if clinically indicated. The first mammography was
routinely carried out 18 months after the operation and earlier only
ifclinically indicated. Preoperative mammographs were available
for all patients for comparison.
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Mammograms were performed in the Department ofRadiology
of Tampere University Hospital, and two radiologists with long
experience in mammography and working in the hospital inter-
preted the films in their routine clinical work blindly and even
without knowing that the study was in progress.
The number of mammograms in the randomized groups was
estimated per patient and per follow-up year. The number of extra
diagnostic examinations (extra mammogram examinations, ultra-
sound, fine-needle aspiration or biopsy) and the occurrence of
positive mammographic findings were assessed per mammo-
graphy session and per follow-up year.
A routine mammography examination consisted of craniocaudal
and mediolateral oblique views. After seeing these films the radiol-
ogist normally decides if a magnified view or ultrasound is neces-
sary andthese are taken during the same visit. This was notregarded
as an extra examination. Only those cases that were regarded as
unclear and in need of more clarification with other methods or
repetition ofthe same kind ofexaminations as before were counted
as positive findings and extra diagnostic examinations.
Two-sided P-values by Fisher's exact test were used to test the
significance ofthe findings. Odds ratios and 95% confidence inter-
vals are presented for the effect of time of follow-up to the extra
diagnostic tests.
RESULTS
There were 144 patients in all, 78 in the radiotherapy and 66 in the
non-radiotherapy group. No differences were seen between the
intervention groups in age of patients or other prognostic factors
(Table 1). The characteristics of tumours and the surgical treat-
ment were fixed in the inclusion criteria. The number of bilateral
mammograms taken was 239 during the mean follow-up time of
2.9 years, i.e. 411 cumulative follow-up years (Table 2); this corre-
sponded to 1.7 mammograms per patient and 0.6 mammograms
per follow-up year. The number was about the same as planned,
i.e. about one mammography examination every 18 months. There
was no difference in this respect between the treatment groups.
Altogether 48 patients were sent to mammography earlier than
originally scheduled (range 6-17 months) because of some suspi-
cion in clinical examination or symptoms ofthe patient. However,
for those who had normal findings the next mammography was
delayed so that the average interval between exams was approxi-
mately as originally planned.
Further diagnostic tests after the routine mammography exami-
nation were more frequently called for in the radiotherapy group
(27) than in the non-radiotherapy group (15) (Table 3). However,
the difference was fairly small and not significant (P = 0.14). There
were 0.19 further tests per mammography in the radiotherapy
group and 0.15 in the non-radiotherapy group. The intensity per
Table 1 The Tampere randomized trial on breast-conserving surgery with or
without radiotherapy in breast cancer patients with good prognosis 1990-95.
Patient characteristics by treatment
Characteristic Radiotherapy
Yes No Total
Age (mean) 55.6 56.3 55.9
S-phase (mean) 4.9 4.7 4.8
Histology
Ductal invasive 69 (88%) 57 (86%) 126 (87%)
Lobular invasive 7 (9%) 7 (11%) 14 (10%)
Other invasive 2 (3%) 2 (3%) 4 (3%)
Grade
53 (68%) 47 (71%) 100 (70%)
Other 25 (32%) 19 (29%) 44 (30%)
Total 78 (100%) 66 (100%) 144 (100%)
patient year was also about the same, 0.11 vs 0.09 in both groups
(Table 3). In the radiotherapy group there were five biopsies, 14
fine-needle aspirations in ultrasound control and eight control
mammography examinations with magnified view and ultrasound.
In the non-radiotherapy group the numbers were three, six and six
respectively.
The mammographic finding was classified as positive more
frequently in the radiotherapy group (20) than in the non-
radiotherapy (nine) group, but the difference was not significant
(P = 0.10). Positive findings per mammography were 1.6 times
more frequent in the group with radiotherapy (0.14) than in the
group without (0.09). The positive finding was confirmed to be
recurrent breast cancer, i.e. true positive, in three patients in each
group, and two other patients in the radiotherapy group were oper-
ated on for fat necrosis. Thus, positive findings that turned out to
be negative at confirmation were 2.0 times more frequent per
mammography in the radiotherapy group (17 cases) than in the
non-radiotherapy group (six cases), which was significant
(P = 0.04) (Table 3).
Further tests were called for more often only at the beginning of
follow-up (OR = 2.0 if follow-up < 18 and 1.0 if follow-up was
. 18 months). The tests were performed 4.3 times more often in
theradiotherapy group than in the non-radiotherapy group (Table4).
DISCUSSION
The aim ofpopulation-based mammography screening is to reduce
mortality from breast cancer by detecting preclinical disease.
Mammography has high sensitivity and specificity in detecting
preclinical breast cancer (Miller et al, 1991). This improvement in
the diagnostic method will lead to a significant reduction in
Table 2 The Tampere randomized trial on breast-conserving surgery with radiotherapy (RT) vs without radiotherapy (No-RT)
in breast cancer patients with good prognosis 1990-95. Number of patients, follow-up years and mammography examinations
by treatment
RT No-RT Total
n Per patient n Per patient n Per patient
Number of patients 78 66 144
Follow-up years 238 3.1 173 2.6 411 2.9
Mammography 142 1.8 97 1.5 239 1.7
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Table 3 The Tampere randomized trial on breast-conserving surgery with radiotherapy (RT) vs without radiotherapy (No-RT) in breast cancer patients with
good prognosis 1990-95. Number and frequency of true and false abnormal findings by treatment.
Type of event RT No-RT
Number Per mammography Per follow-up year Number Per mammography Per follow-up year P-value
Further diagnostic testa 27 0.19 0.11 15 0.15 0.09 0.14
Positive finding 20 0.14 0.08 9 0.09 0.05 0.10
Recurrence 3 0.02 0.01 3 0.03 0.02 0.19
Uncertain findings 17 0.12 0.07 6 0.06 0.03 0.04
aFurther diagnostic tests: ultrasound, extra mammography, fine-needle aspiration and/or biopsy.
Table 4 Number, period prevalence (%) and odds ratio of further tests prompted by
mammography by treatment and length of follow-up (months)
Treatment Interval from surgery to mammography examination
Less than 18 18-60
Number Prevalence Number Prevalence
No radiation 3/19 16 6/82 8
Radiation 12/44 27 8/108 8
OR 2.0 1.0
mortality from breast cancer for women of50 years and older (Wald
et al, 1991). Mammography screening also has other advantages
besides possible reduction in mortality, i.e. early detection of breast
cancer allows more conservative treatment and may have a positive
effect on the quality oflife ofbreast cancer patients (de Koning et al,
1992). Because mammography is a valid test for screening it is also
assumed to be effective in the post-treatment follow-up of breast
cancer patients (Sadowsky et al, 1990; Orel et al, 1992; Jager et al,
1995; American Society ofClinical Oncology, 1997).
The risk ofa breast cancer patient developing a second cancer in
the opposite breast is about five times as large as the risk of first
breast cancer in the general population (Brenner et al, 1993). There
is also the risk of a local relapse in the treated breast even ifradio-
therapy is given (Fisher et al, 1995). Radiotherapy is widely used
because it prevents local relapses after conservative surgery (Fisher
et al, 1995). The numbers of local relapses and second cancers in
this study (three vs three) were too small for valid conclusions.
There is so far no evidence that routine follow-up for recurrence
produces any useful diagnostic lead-time or prolongs survival
(GIVIO Investigators, 1994). However, the routine use of
mammography has generally been recommended for the contra-
lateral and ipsilateral breast in women of any age with a history of
breast cancer (American Society ofClinical Oncology, 1997). The
recommendations are based on retrospective studies that have
shown that mammography detects ipsilateral breast cancer
recurrences and second cancers smaller than them are detected by
physical examination (Mellik et al, 1991; Orel et al, 1992; Barr
et al, 1993; Jager et al, 1995).
Radiotherapy changes the breast and causes fat necrosis,
fibrosis, skin thickening and other parenchymal distortion, which
might further cause diagnostic problems (Welch, 1986). In our
randomized study the interpretation of mammography in normal
clinical practice was more difficult after radiotherapy than after
conservative surgery alone, and gave rise to extra diagnostic tests
and positive findings. Patients have a fear of recurrence after
breast cancer and diagnostic tests, and in particular a positive
result may increase anxiety and fear (Marteau 1989, 1990).
Waiting for the next mammography examination and knowing that
the previous was not considered absolutely normal is stressful for
the patient and should be avoided.
The false-positive mammography examination was more
frequent at the beginning of follow-up, especially in the radio-
therapy group. Extra tests were common in the radiotherapy group
during the first 18 months but not after this as compared with
patients treated with surgery alone. The optimal frequency ofpost-
treatment mammography has not been established. It seems to
vary from 6 to 24 months in clinical practice in different centres
(Recht et al, 1989; Sadowsky et al, 1990; Orel et al, 1992; Rosselli
del Turco et al, 1994; GIVIO Investigators, 1994). The American
Society of Clinical Oncology has recently recommended that after
conservative therapy the first mammography should be taken 6
months after completion of radiotherapy and annually after that.
Our results indicate that local relapse is rare in low-risk patients
and that mammograms shortly after radiotherapy cause extra tests
and stress for the patient compared with mammograms after
conservative surgery only. Furthermore, the breast is often swollen
and painful after treatment and mammography may cause harm to
the breast and inconvenience to the patient. We propose that the
first post-treatment mammography should not be taken in the
first 1/2 years after primary treatment, especially in patients with a
low risk of recurrence and who have been subjected to radiation
treatment.
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